As a clinician, educator, and emotion researcher, I have long believed that our efforts to optimise the wellbeing of health-care professionals are doomed if we cannot talk openly about the emotional ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

If observed trends over the past 30 years continue, the total number of adults ages 25 and older living with overweight (body ...

Hemorrhage—severe heavy bleeding—and hypertensive disorders like preeclampsia are the leading causes of maternal deaths ...

as well as after the term "lancet arch", a window with a sharp pointed arch, to indicate the "light of wisdom" or "to let in light". It publishes original research articles, review articles ...

The study, published in The Lancet Global Health, marks WHO’s first comprehensive update on maternal mortality causes since ...

Hemorrhage – severe heavy bleeding – and hypertensive disorders like preeclampsia are the leading causes of maternal deaths globally, according to a new study released today by the World Health ...

The largest number of adults predicted to be overweight and obese by 2025 are expected to be in China (627m), India (450m) ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

The research, led by Murdoch Children’s Research Institute (MCRI) and published in The Lancet, found a third of children and ... coordinated global action across the entire developmental window to ...

Given at 30 through 33 weeks, the oxytocin receptor antagonist atosiban was linkegestation time but nod to longer t better ...

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.